Radiotracers for Molecular Imaging of Cyclooxygenase-2 (COX-2) Enzyme
Overview
Authors
Affiliations
Cyclooxygenase (COX) enzyme is responsible for the formation of important biological mediators including prostaglandins, prostacyclin and thromboxane to trigger many physiological and patho-physiological responses. COXs exist in two distinct isoforms, a constitutively expressed form (COX-1) and an inducible form (COX-2). COX-2 is involved in the body's response to inflammation and pain. Moreover, it has also been shown that COX-2 is overexpressed in many human cancers, and that COX-2 is involved in various neurodegenerative diseases such as Parkinson's and Alzheimer's disease. COX-2 inhibitors are among the most widely used therapeutics for the treatment of chronic and acute pain and inflammation. Non-invasive monitoring of COX-2 functional expression by means of nuclear molecular imaging techniques like positron emission tomography (PET) and single photon emission computed tomography (SPECT) might provide unique opportunities to obtain data on COX-2 expression levels during disease manifestation and progression to study potential roles of COX-2 under various pathological conditions. The present review summarizes recent research efforts directed to the design and synthesis of radiotracers as molecular probes with special emphasis on COX-2 imaging.
Uzuegbunam B, Rummel C, Librizzi D, Culmsee C, Yousefi B Int J Mol Sci. 2023; 24(24).
PMID: 38139248 PMC: 10743508. DOI: 10.3390/ijms242417419.
Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective.
Chahal S, Rani P, Kiran , Sindhu J, Joshi G, Ganesan A ACS Omega. 2023; 8(20):17446-17498.
PMID: 37251190 PMC: 10210234. DOI: 10.1021/acsomega.3c00692.
Lemm S, Kohler S, Wodtke R, Jung F, Kupper J, Pietzsch J Cells. 2022; 11(15).
PMID: 35954291 PMC: 9368227. DOI: 10.3390/cells11152447.
Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2.
Kaur J, Bhardwaj A, Wuest F Molecules. 2022; 27(12).
PMID: 35744851 PMC: 9227202. DOI: 10.3390/molecules27123722.
Laube M, Gassner C, Neuber C, Wodtke R, Ullrich M, Haase-Kohn C RSC Adv. 2022; 10(63):38601-38611.
PMID: 35517533 PMC: 9057277. DOI: 10.1039/d0ra04494f.